Form 4: Macrogenics Executive Exercises Stock Options, Disposes of Shares

Ezio Bonvini, Sr VP, Research & CSO of Macrogenics, exercised stock options and disposed of shares on February 15, 2025.

Summary

• On February 15, 2025, Ezio Bonvini, the Senior Vice President, Research & CSO of Macrogenics Inc. (MGNX), exercised restricted stock units and disposed of the underlying common stock.
• The transaction involved the exercise of 16,665 restricted stock units, which converted into common stock on a one-for-one basis.
• Following the transaction, Bonvini directly owns 16,665 derivative securities and 124,414 shares of common stock.

Sentiment

Score: 5

Explanation: This is a neutral event, simply reflecting the execution of previously granted stock options. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine insider transaction.

Key Dates

Keywords

Macrogenics, MGNX, Ezio Bonvini, Stock Options, Restricted Stock Units, Form 4, Insider Trading, Beneficial Ownership, Securities Exchange Act